BOTOX® has now been approved as a preventive treatment for chronic migraine by UK drug regulators; after having been approved by the FDA in the US. This will come as a welcome relief to know there is another treatment to add to the list as most sufferers really struggle to find a treatment that is totally effective.

The approvals come after a trial of more than 1,300 patients showed success in reducing the frequency of headaches.

The MHRA (medicines and healthcare products regulatory agency) said only patients who suffer headaches for at least 2 weeks a month, half of which come with migraine symptoms, are eligible.